I am at a crossroad here. Recently became castrate resistant in March. Went on an immunotherapeutic clinical trial recommended by Dr Drake on April 8. Evaluation today shows progression of my lymph node Mets and slight increase in my L2 met. More concerning is my PSADT of 1 month since the clinical trial began. (4.5 to 9 to 18). I was floored. So my options now are to continue with the trial to see if I get a delayed immunotherapy response vs switching to another therapy. I guess the most reasonable alternative options at this time are chemo vs Lu177 (or Ac225). Would appreciate anyone’s opinion before I discuss with Dr. Drake.
Thanks.